Fig. 10From: Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapiesPolymer/nanomicelles-based transdermal drug delivery platform for the treatment of psoriasis. Lipid-polymer hybrid nanoparticles were fabricated to load clobetasol propionate for enhancement of its cellular uptake and skin permeability to improve antipsoriatic efficacy. Reproduced with permission [11]. Copyright 2020, ElsevierBack to article page